Literature DB >> 24626968

Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand.

Ernieda Hatah1, June Tordoff, Stephen B Duffull, Claire Cameron, Rhiannon Braund.   

Abstract

BACKGROUND: Poor adherence to medication can lead to suboptimal outcomes, and is reported to occur frequently. Pharmacists in some countries are funded to support the appropriate use of medications in patients and enhance medication adherence, by providing services such as Medicines Use Review (MUR).
OBJECTIVE: To describe and investigate factors that may influence patients' knowledge and perceptions of and adherence to medications as determined during MUR.
SETTING: Community pharmacies in a locality in New Zealand. Method Following consent from five MUR service providers, records of patients' MUR consultations conducted between November 2007 and December 2011 were retrospectively reviewed for information on patients, services, and outcomes. Using multilevel mixed-effects logistic regression, factors that predicted the providers' score of the patients' medication knowledge, and the patients' score of their adherence to and perceptions of medications, were investigated. Main outcome measure patients' knowledge, perceptions and adherence scores.
RESULTS: A total of 353 MUR patients' records were evaluated. The median (IQR) age of patients was 73 (63-81) years. About 41.1 % of patients were Māori. A total of 204 (57.8 %) patients had two MUR consultations and only 53 (15 %) had four. The mean score of patients' knowledge, perceptions of, and adherence to medications were found to increase in each visit which suggests that adherence support by pharmacists might improve patients' outcomes. Females had higher medication knowledge scores than males (OR 3.09, 95 % CI 1.29-7.44). There was some evidence to suggest Māori had lower scores for knowledge of medications than non-Māori (OR 0.092, 95 % CI 0.02-0.36). In addition, longer duration in the program predicted better scores for medication knowledge, adherence and perceptions of medications.
CONCLUSIONS: MUR was found to have the potential to improve the scores of patients' knowledge and perceptions of and adherence to medicines, and factors such as gender, ethnicity and longer duration in the services were found to predict these outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24626968     DOI: 10.1007/s11096-014-9913-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  18 in total

1.  National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: toward better patient outcomes and new roles for pharmacists.

Authors:  David Hawkins; J Chris Bradberry; Mark J Cziraky; Robert L Talbert; David W Bartels; Joli D Cerveny
Journal:  Pharmacotherapy       Date:  2002-04       Impact factor: 4.705

2.  Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008.

Authors:  Evan Lee; Rhiannon Braund; June Tordoff
Journal:  N Z Med J       Date:  2009-04-24

3.  Correlates of medication knowledge and adherence: findings from the residency research network of South Texas.

Authors:  Sandra Burge; Darryl White; Ellen Bajorek; Oralia Bazaldua; Juan Trevino; Theresa Albright; Frank Wright; Leo Cigarroa
Journal:  Fam Med       Date:  2005 Nov-Dec       Impact factor: 1.756

4.  Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes.

Authors:  Harith Kh Al-Qazaz; Syed A Sulaiman; Mohamed A Hassali; Asrul A Shafie; Shameni Sundram; Rana Al-Nuri; Fahad Saleem
Journal:  Int J Clin Pharm       Date:  2011-11-15

5.  The consumption of drugs by 75-year-old individuals living in their own homes.

Authors:  I Barat; F Andreasen; E M Damsgaard
Journal:  Eur J Clin Pharmacol       Date:  2000-09       Impact factor: 2.953

6.  Functional health literacy is associated with health status and health-related knowledge in people living with HIV-AIDS.

Authors:  S C Kalichman; D Rompa
Journal:  J Acquir Immune Defic Syndr       Date:  2000-12-01       Impact factor: 3.731

7.  Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany.

Authors:  Diana Witticke; Hanna M Seidling; Kristina Lohmann; Alexander F J Send; Walter E Haefeli
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

8.  Drug non-adherence and associated risk factors among Chinese geriatric patients in Hong Kong.

Authors:  P W Lam; C M Lum; M F Leung
Journal:  Hong Kong Med J       Date:  2007-08       Impact factor: 2.227

Review 9.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

Review 10.  Inappropriate medication use among the elderly: a systematic review of administrative databases.

Authors:  Lusiele Guaraldo; Fabíola G Cano; Glauciene S Damasceno; Suely Rozenfeld
Journal:  BMC Geriatr       Date:  2011-11-30       Impact factor: 3.921

View more
  4 in total

1.  Pilot study, in a rental retirement village, of an "AdherenceCheck" on the management of medicines by the older-aged.

Authors:  Sheila A Doggrell
Journal:  Int J Clin Pharm       Date:  2017-02-25

2.  Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial.

Authors:  Markus Messerli; Eva Blozik; Noortje Vriends; Kurt E Hersberger
Journal:  BMC Health Serv Res       Date:  2016-04-23       Impact factor: 2.655

3.  Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.

Authors:  Joanna Ulley; Deborah Harrop; Ali Ali; Sarah Alton; Sally Fowler Davis
Journal:  BMC Geriatr       Date:  2019-01-18       Impact factor: 3.921

4.  Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial.

Authors:  Urška Nabergoj Makovec; Igor Locatelli; Mitja Kos
Journal:  BMC Health Serv Res       Date:  2021-03-22       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.